Feasibility & strategy advisory
- Target triage and computational feasibility
- Roadmap for an in silico design programme
- Strategic recommendation document
Structural biology consulting, computational sequence engineering and in silico drug discovery partnerships — from feasibility studies to spin-off support.
From feasibility to implementation — across the full development process.
ProtoVela works as an embedded computational partner for biotech and pharma teams. We translate complex protein data into decisions you can actually act on: feasibility studies, target triage, computational sequence engineering and in silico drug discovery partnerships. The result is clarity on questions that would otherwise consume months of lab time.
For biotech spin-offs and emerging protein engineering companies in Germany and across Europe, we build IP-aware design workflows from day one, so ownership and freedom-to-operate are clean from the start. Generative protein designs we deliver belong fully to you.
Engagements scale modularly — from focused expert advisory to discrete design projects, all the way to long-term co-development of an AI-driven protein engineering platform tailored to your pipeline.
Typical outcomes include technical due-diligence reports, design strategies for a whole program, prioritized candidate lists with risk analysis, and reproducible workflows that your team can continue to run internally.
Related expertiseFive entry points into ProtoVela — from process and proof to the intro call.
Services, molecule classes and scientific application areas in detail.
Principles, optimisation targets and the eight-step design process.
Team, location and scientific leadership behind ProtoVela.
Field notes on AI, structural biology and protein design.
Book a free intro call and Project Assessment.